Previous Article | Next Article ![]()
Infect. Immun., Aug 1997, 3017-3023, Vol 65, No. 8
J Healer, D McGuinness, P Hopcroft, S Haley, R Carter and E Riley
Antibodies to the sexual-stage surface antigens of Plasmodium falciparum,
Pfs230 and Pfs48/45, can abolish the infectivity of gametes to mosquitoes;
these antigens have been proposed as candidates for inclusion in a malaria
transmission-blocking vaccine. One possible mechanism of antibody-mediated
transmission blocking is complement- mediated gamete lysis. We have used a
panel of human sera from geographically distinct regions where malaria is
endemic to investigate whether this may be a mechanism of naturally
acquired transmission- blocking immunity to P. falciparum. By
immunoprecipitation, we have shown that antibody recognition of Pfs230 and
Pfs48/45 is limited, despite universal exposure to P. falciparum
gametocytes. In vitro complement-mediated lysis of P. falciparum gametes
was positively associated with the presence of antibodies to Pfs230 but not
with antibodies to the N-terminal region of the precursor molecule
(Pfs260), which is shed from the gametocyte surface at the time of
gametogenesis. Similarly, antibodies to two other gametocyte-specific
proteins, Pfs48/45 and Pfg27/25, were not associated with gamete lysis. All
sera which mediate gamete lysis contain immunoglobulin G1 (IgG1) and/or
IgG3 antibodies to gamete surface proteins as determined by an
enzyme-linked immunosorbent assay. These data suggest that Pfs230 is a
major target of complement-fixing antibodies which may be important for
antibody- mediated transmission-blocking immunity.
Copyright © 1997, American Society for Microbiology
Complement-mediated lysis of Plasmodium falciparum gametes by malaria- immune human sera is associated with antibodies to the gamete surface antigen Pfs230
Institute of Cell, Animal and Population Biology, Division of Biological Sciences, University of Edinburgh, Scotland, United Kingdom. Julie.healer@ed.ac.uk
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|